Laurence Keller

Laurence Keller has been Chief Medical Officer of Aldagen, Inc. since December, 2007.
He is a Fellow of the American College of Cardiology and a Member of the American Heart Association.
Prior to joining Aldagen, Dr. Keller was Senior Medical Director of Kos Pharmaceuticals, Inc. from November, 2005 to August, 2007.
Previously, he was Director of Clinical Research and Development and Senior Director for Pfizer/Parke Davis from 1999 to November, 2005.
Dr. Keller received a BS degree and an MD from George Washington University and an MS degree in Physiology from Georgetown University.
He is a Board-Certified Pediatric Cardiologist.